Hengrui Pharmaceutical (01276) had repurchased a total of 1,636,200 A-shares as of the end of October

According to Zhitong Finance App, Hengrui Pharmaceutical (01276) issued an announcement. As of October 31, 2026, the company's share repurchase plan was a total of 1,6362 million A-share shares through the Shanghai Stock Exchange trading system. The repurchased shares accounted for 0.025% of the company's total share capital. The highest purchase price was RMB 46.33 yuan/share, and the lowest price was RMB 43.10 per share. The total amount paid was RMB 73.8849 million (excluding transaction fees).